Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;73(4):1063-1078.
doi: 10.1007/s43440-021-00269-5. Epub 2021 May 22.

Shedding light on the role of CX3CR1 in the pathogenesis of schizophrenia

Affiliations
Review

Shedding light on the role of CX3CR1 in the pathogenesis of schizophrenia

Katarzyna Chamera et al. Pharmacol Rep. 2021 Aug.

Abstract

Schizophrenia has a complex and heterogeneous molecular and clinical picture. Over the years of research on this disease, many factors have been suggested to contribute to its pathogenesis. Recently, the inflammatory processes have gained particular interest in the context of schizophrenia due to the increasing evidence from epidemiological, clinical and experimental studies. Within the immunological component, special attention has been brought to chemokines and their receptors. Among them, CX3C chemokine receptor 1 (CX3CR1), which belongs to the family of seven-transmembrane G protein-coupled receptors, and its cognate ligand (CX3CL1) constitute a unique system in the central nervous system. In the view of regulation of the brain homeostasis through immune response, as well as control of microglia reactivity, the CX3CL1-CX3CR1 system may represent an attractive target for further research and schizophrenia treatment. In the review, we described the general characteristics of the CX3CL1-CX3CR1 axis and the involvement of this signaling pathway in the physiological processes whose disruptions are reported to participate in mechanisms underlying schizophrenia. Furthermore, based on the available clinical and experimental data, we presented a guide to understanding the implication of the CX3CL1-CX3CR1 dysfunctions in the course of schizophrenia.

Keywords: CX3CL1; CX3CR1; Schizophrenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest, financial or otherwise.

Figures

Fig. 1
Fig. 1
Scheme illustrating the structure, localization and signaling pathways affected by the CX3CL1–CX3CR1 axis. CX3CL1, produced mostly by neurons, is a membrane-bound molecule with a chemokine domain, mucin-like stalk, transmembrane region and cytoplasmic tail. Cleavage of CX3CL1 is mediated under physiological or pathological conditions by ADAM10 or ADAM17, MMP-2, MMP-3 and cathepsin S, respectively. Binding CX3CL1 to CX3CR1, which is a seven-transmembrane domain Gi protein-coupled receptor expressed primarily on microglia, results in an intracellular transmission engaging multiple signaling pathways. TM transmembrane domain, EL extracellular loop, IL intracellular loop
Fig. 2
Fig. 2
The role of the CX3CL1–CX3CR1 signaling pathway in the pathology of schizophrenia. In physiological conditions, the interaction of CX3CL1 with CX3CR1 is essential for the regulation of multiple processes in the brain. The disturbances within this axis and subsequent disruptions within these mechanisms implicate the CX3CL1–CX3CR1 dyad in schizophrenia

References

    1. Rössler W, Joachim Salize H, Van Os J, Riecher-Rössler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 2005;15:399–409. doi: 10.1016/j.euroneuro.2005.04.009. - DOI - PubMed
    1. Chong HY, Teoh SL, Wu DBC, Kotirum S, Chiou CF, Chaiyakunapruk N. Global economic burden of schizophrenia: a systematic review. Neuropsychiatr Dis Treat. 2016;12:357–373. doi: 10.2147/NDT.S96649. - DOI - PMC - PubMed
    1. Charlson FJ, Ferrari AJ, Santomauro DF, Diminic S, Stockings E, Scott JG, et al. Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophr Bull. 2018;44:1195–1203. doi: 10.1093/schbul/sby058. - DOI - PMC - PubMed
    1. Jaaro-Peled H, Sawa A. Neurodevelopmental factors in schizophrenia. Psychiatr Clin N Am. 2020;43:263–274. doi: 10.1016/j.psc.2020.02.010. - DOI - PubMed
    1. Silveira C, Marques-Teixeira J, De Bastos-Leite AJ. More than one century of schizophrenia: an evolving perspective. J Nerv Ment Dis. 2012;200:1054–1057. doi: 10.1097/NMD.0b013e318275d249. - DOI - PubMed